XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Tables)
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Disaggregation of Revenue
Below is a summary of net sales by each class of product (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
Advanced Wound Care
     Tissue/Other$56,035 $50,842 $156,012 $137,975 
     Cord6,247 4,227 17,093 11,387 
Total Advanced Wound Care62,282 55,069 173,105 149,362 
Section 351489 8,195 17,187 23,084 
Other(1)
303 1,039 914 7,240 
Total$63,074 $64,303 $191,206 $179,686 
(1) “Other” represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.
Below is a summary of net sales by each customer type (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
Direct Customers$61,087 $62,409 $184,706 $175,060 
Distributors1,987 1,894 6,500 4,626 
Total$63,074 $64,303 $191,206 $179,686 
Assessment of Revenue under ASC 606
A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and nine months ended September 30, 2021 and 2020 are as follows (amounts in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2021202020212020
Net sales$303 $1,039 $914 $7,240 
Cost of sales42 146 128 1,014 
Gross profit$261 $893 $786 $6,226